Literature DB >> 27446395

Predicting associations between microRNAs and target genes in breast cancer by bioinformatics analyses.

Tianying Zheng1, Xing Zhang1, Yonggang Wang1, Xiucui Yu1.   

Abstract

Breast cancer is the leading type of cancer among females. However, the association between microRNAs (miRNAs) and target genes in breast tumorigenesis is poorly studied. The original data set GSE26659 was downloaded from the Gene Expression Omnibus, and then the differentially expressed miRNAs among 77 breast cancer patients and 17 controls were identified using the Limma package in R software. Furthermore, breast cancer-related differentially expressed miRNAs were selected from a human miRNA disease database and their target genes were selected from five miRNA databases. Then, functional analysis was performed for the target genes followed by construction of a miRNA-target gene network. A total of 34 differentially expressed miRNAs were identified, including 13 breast cancer-related miRNAs. Moreover, the target genes of the 13 miRNAs were significantly enriched in regulation of transcription (P=7.43E-09) and pathways related to cancer (P=3.33E-11). Finally, eight upregulated miRNAs (including hsa-miR-425) and five downregulated miRNAs (including hsa-miR-143, hsa-miR-145 and hsa-miR-125b) were identified in the miRNA-target gene network. In conclusion, using bioinformatics approaches, we demonstrate that the changes in regulation of transcription and cancer pathways may play significant roles in the process of breast cancerogenesis. Differentially expressed miRNAs and their target genes may be new targets for breast cancer therapy.

Entities:  

Keywords:  breast cancer; differentially expressed microRNA; functional analysis; protein-protein interaction network

Year:  2016        PMID: 27446395      PMCID: PMC4950656          DOI: 10.3892/ol.2016.4731

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis.

Authors:  Claire L Wilson; Crispin J Miller
Journal:  Bioinformatics       Date:  2005-08-02       Impact factor: 6.937

3.  Prediction of both conserved and nonconserved microRNA targets in animals.

Authors:  Xiaowei Wang; Issam M El Naqa
Journal:  Bioinformatics       Date:  2007-11-29       Impact factor: 6.937

4.  miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer.

Authors:  Hailin Tang; Peng Liu; Lu Yang; Xinhua Xie; Feng Ye; Minqing Wu; Xiaoping Liu; Bo Chen; Lijuan Zhang; Xiaoming Xie
Journal:  Mol Cancer Ther       Date:  2014-10-15       Impact factor: 6.261

5.  Role of microRNAs in the regulation of breast cancer stem cells.

Authors:  Suling Liu; Shawn G Clouthier; Max S Wicha
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-02-14       Impact factor: 2.673

6.  Polymorphism of chicken myocyte-specific enhancer-binding factor 2A gene and its association with chicken carcass traits.

Authors:  Yan Zhou; Yiping Liu; Xiaosong Jiang; Huarui Du; Xiaocheng Li; Qing Zhu
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

7.  A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.

Authors:  Ankur K Nagaraja; Chad J Creighton; Zhifeng Yu; Huifeng Zhu; Preethi H Gunaratne; Jeffrey G Reid; Emuejevoke Olokpa; Hiroaki Itamochi; Naoto T Ueno; Shannon M Hawkins; Matthew L Anderson; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2010-01-15

8.  Identification of differentially expressed microRNAs in human male breast cancer.

Authors:  Ulrich Lehmann; Thomas Streichert; Benjamin Otto; Cord Albat; Britta Hasemeier; Henriette Christgen; Elisa Schipper; Ursula Hille; Hans H Kreipe; Florian Länger
Journal:  BMC Cancer       Date:  2010-03-23       Impact factor: 4.430

9.  Leri's pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesis.

Authors:  Siddharth Banka; Stuart A Cain; Sabrya Carim; Sarah B Daly; Jill E Urquhart; Günhan Erdem; Jade Harris; Michelle Bottomley; Dian Donnai; Bronwyn Kerr; Helen Kingston; Andreas Superti-Furga; Sheila Unger; Holly Ennis; Jane Worthington; Ariane L Herrick; Catherine L R Merry; Wyatt W Yue; Cay M Kielty; William G Newman
Journal:  Ann Rheum Dis       Date:  2014-01-17       Impact factor: 19.103

10.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations.

Authors:  Yang Li; Chengxiang Qiu; Jian Tu; Bin Geng; Jichun Yang; Tianzi Jiang; Qinghua Cui
Journal:  Nucleic Acids Res       Date:  2013-11-04       Impact factor: 16.971

View more
  9 in total

1.  miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.

Authors:  Dengfeng Li; Jiashu Hu; Hongming Song; Hui Xu; Chengyang Wu; Bingkun Zhao; Dan Xie; Tianqi Wu; Junyong Zhao; Lin Fang
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

2.  Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.

Authors:  Jing Yao; Zhe Yang; Jun Yang; Zhi-Gang Wang; Zheng-Yun Zhang
Journal:  Aging (Albany NY)       Date:  2021-05-23       Impact factor: 5.682

3.  miR-937 regulates the proliferation and apoptosis via targeting APAF1 in breast cancer.

Authors:  Huiying Fang; Wei Jiang; Zhouhong Jing; Xiaosong Mu; Zhongxun Xiong
Journal:  Onco Targets Ther       Date:  2019-07-17       Impact factor: 4.147

4.  MiR-942 regulates the function of breast cancer cell by targeting FOXA2.

Authors:  Jinku Zhang; Zhiqiang Zhang; Jirui Sun; Qiushuang Ma; Wenming Zhao; Xue Chen; Haizhi Qiao
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

5.  Loss of miR-100 and miR-125b results in cancer stem cell properties through IGF2 upregulation in hepatocellular carcinoma.

Authors:  Hyang Sook Seol; Yoshimitsu Akiyama; San-Eun Lee; Shu Shimada; Se Jin Jang
Journal:  Sci Rep       Date:  2020-12-08       Impact factor: 4.379

Review 6.  A Systematic Review of Clinical Validated and Potential miRNA Markers Related to the Efficacy of Fluoropyrimidine Drugs.

Authors:  Xiaomeng Sun; Jiani Chen; Xintao Chen; Qianmin Gao; Wei Chen; Xun Zou; Feng Zhang; Shouhong Gao; Shi Qiu; Xiaoqiang Yue; Houshan Yao; Xuan Liu; Mingming Li
Journal:  Dis Markers       Date:  2022-08-23       Impact factor: 3.464

7.  Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.

Authors:  Charles Johannessen; Line Moi; Yury Kiselev; Mona Irene Pedersen; Stig Manfred Dalen; Tonje Braaten; Lill-Tove Busund
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

8.  MiR-145 functions as a tumor suppressor in Papillary Thyroid Cancer by inhibiting RAB5C.

Authors:  Wei Zhang; Wenyue Ji; Tianshu Li; Ting Liu; Xudong Zhao
Journal:  Int J Med Sci       Date:  2020-07-25       Impact factor: 3.738

9.  Identification of breast cancer risk modules via an integrated strategy.

Authors:  Wan Li; Gui Deng; Ji Zhang; Erqiang Hu; Yuehan He; Junjie Lv; Xilin Sun; Kai Wang; Lina Chen
Journal:  Aging (Albany NY)       Date:  2019-12-20       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.